BioSpace News Archive

Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report first quarter 2021 financial results on Wednesday, April 28, 2021, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Company’s website at http://investor.aligntech.com .

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its first quarter 2021 financial results on Thursday, April 29, 2021, prior to its earnings call at 8:00 a.m. ET.

CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2021 after the market close on Wednesday, April 28, 2021. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2021 financial results after market close on Thursday, April 29, 2021. Management will hold a conference call to review the company’s first quarter 2021 performance starting at 4:30 p.m. (Eastern Time) on the same day.

ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, announced that on March 31, 2021 the compensation committee of the Company’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 29,500 shares of its common stock to two employees under the ImmunoGen, Inc. Inducement Equity Incentive Plan.

Vyant Bio, Inc. (the “Company”) (Nasdaq: VYNT), is a new force in drug discovery focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery and development of therapeutics for biopharma partners as well as for the proprietary pipeline of the Company. Today, Vyant Bio announced that an investor webcast will be hosted on Tuesday, April 6, 2021.

the U.S. Food and Drug Administration announced two revisions regarding the number of doses per vial available for the Moderna COVID-19 Vaccine.

Unwavering R&D initiatives is compelling government entities to sanction research projects incorporating advanced genetic analyzer systems

According to the report, the global medical nonwoven disposables market was valued at US$ 14.4 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2020 to 2028.

Folliculotropic mycosis fungoides, one type of cutaneous T-cell lymphoma is a rare disease in which white blood cells, namely lymphocytes become harmful or cancerous causing adverse effect on skin.